Edition:
United Kingdom

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

132.80SEK
10:46am BST
Change (% chg)

5.45kr (+4.28%)
Prev Close
127.35kr
Open
129.00kr
Day's High
132.90kr
Day's Low
129.00kr
Volume
1,248,283
Avg. Vol
1,436,236
52-wk High
132.90kr
52-wk Low
97.12kr

Latest Key Developments (Source: Significant Developments)

Elekta CEO says expects effects from China purchasing programme this year
Wednesday, 29 May 2019 

May 29 (Reuters) - Elekta AB (publ) CEO in interview with Reuters ::ELEKTA CEO SAYS DON'T YET SEE EFFECT OF CHINA'S MEDICAL EQUIPMENT PURCHASING PROGRAMME, "DEFINITELY" EXPECTS EFFECTS TO COME THIS FISCAL YEAR.  Full Article

Elekta Q4 EBIT SEK 755 Million, Above Estimates
Wednesday, 29 May 2019 

May 29 (Reuters) - Elekta AB (publ) ::Q4 NET SALES SEK 4.1 BILLION .Q4 GROSS ORDER INTAKE SEK 5.40 BILLION VERSUS SEK 4.66 BILLION YEAR AGO.REUTERS POLL: ELEKTA AB Q4 EBIT SEEN AT SEK 653 MILLION; NET SALES AT SEK 3,712 MILLION; GROSS ORDER INTAKE AT SEK 5,092 MILLION.Q4 OPERATING RESULT SEK 755 MILLION.PROPOSES DIVIDEND OF SEK 1.80 PER SHARE FOR FY 2018/2019 (REUTERS POLL: SEK 1.28 PER SHARE).OUTLOOK 2019/20: NET SALES GROWTH OF 8-10 PERCENT.OUTLOOK 2019/20: EBITA-MARGIN OF ABOUT 19 PERCENT.SAYS ALL PRODUCTION AREAS CONTRIBUTED TO GROWTH.SAYS WE EXCEEDED ANNUAL NET SALES TARGET AND DELIVERED ON REVISED EBITA MARGIN TARGET.SAYS DURING FINAL QUARTER WE DELIVERED A GOOD PERFORMANCE.SAYS WE ACHIEVED STRONG NET SALES GROWTH AND CONTINUED A ROBUST ORDER TREND OVERALL.SAYS DURING YEAR DEMAND FOR RADIATION THERAPY SOLUTIONS REMAINED STRONG IN ALL REGIONS..SAYS ALL BUSINESS LINES CONTRIBUTED TO GROWTH, BOTH IN SOLUTIONS AND SERVICES.SAYS LEKSELL GAMMA KNIFE® ALSO HAD.SAYS LEKSELL GAMMA KNIFE® ALSO HAD A VERY STRONG DEVELOPMENT, COMING CLOSE TO STRONGEST YEAR OF ITS HISTORY.SAYS ELEKTA UNITY HAD A GOOD PERFORMANCE WITH HEALTHY ORDER INTAKE AND SALES.SAYS HOWEVER, SOME OF EXPECTED ORDERS FOR Q4 SHIFTED INTO NEW FISCAL YEAR DUE TO LONGER PROCUREMENT PROCESSES WITH UNITY.SAYS OUR EBITA MARGIN IS EXPECTED TO IMPROVE AS WE BENEFIT FROM OUR PROCESS ENHANCING EFFORTS, COGS REDUCTION PROGRAM AND A CONTINUED REVENUE GROWTH FROM OUR INVESTMENTS IN UNITY AND CHINA.  Full Article

BRIEF-Elekta Q4 EBIT SEK 755 Million, Above Estimates
Wednesday, 29 May 2019 

Repeats brief to include alerts relating to Q4 results.:Q4 NET SALES SEK 4.1 BILLION .Q4 GROSS ORDER INTAKE SEK 5.40 BILLION VERSUS SEK 4.66 BILLION YEAR AGO.REUTERS POLL: ELEKTA AB Q4 EBIT SEEN AT SEK 653 MILLION; NET SALES AT SEK 3,712 MILLION; GROSS ORDER INTAKE AT SEK 5,092 MILLION.Q4 OPERATING RESULT SEK 755 MILLION.PROPOSES DIVIDEND OF SEK 1.80 PER SHARE FOR FY 2018/2019 (REUTERS POLL: SEK 1.28 PER SHARE).OUTLOOK 2019/20: NET SALES GROWTH OF 8-10 PERCENT.OUTLOOK 2019/20: EBITA-MARGIN OF ABOUT 19 PERCENT.SAYS ALL PRODUCTION AREAS CONTRIBUTED TO GROWTH.SAYS WE EXCEEDED ANNUAL NET SALES TARGET AND DELIVERED ON REVISED EBITA MARGIN TARGET.SAYS DURING FINAL QUARTER WE DELIVERED A GOOD PERFORMANCE.SAYS WE ACHIEVED STRONG NET SALES GROWTH AND CONTINUED A ROBUST ORDER TREND OVERALL.SAYS DURING YEAR DEMAND FOR RADIATION THERAPY SOLUTIONS REMAINED STRONG IN ALL REGIONS..SAYS ALL BUSINESS LINES CONTRIBUTED TO GROWTH, BOTH IN SOLUTIONS AND SERVICES.SAYS LEKSELL GAMMA KNIFE® ALSO HAD.SAYS LEKSELL GAMMA KNIFE® ALSO HAD A VERY STRONG DEVELOPMENT, COMING CLOSE TO STRONGEST YEAR OF ITS HISTORY.SAYS ELEKTA UNITY HAD A GOOD PERFORMANCE WITH HEALTHY ORDER INTAKE AND SALES.SAYS HOWEVER, SOME OF EXPECTED ORDERS FOR Q4 SHIFTED INTO NEW FISCAL YEAR DUE TO LONGER PROCUREMENT PROCESSES WITH UNITY.SAYS OUR EBITA MARGIN IS EXPECTED TO IMPROVE AS WE BENEFIT FROM OUR PROCESS ENHANCING EFFORTS, COGS REDUCTION PROGRAM AND A CONTINUED REVENUE GROWTH FROM OUR INVESTMENTS IN UNITY AND CHINA.  Full Article

Elekta Says Unity MR-Linac Receives Regulatory Approval For Clinical Use In Japan
Thursday, 23 May 2019 

May 23 (Reuters) - Elekta AB (publ) ::ELEKTA UNITY MR-LINAC RECEIVES REGULATORY APPROVAL FROM JAPANESE MINISTRY OF HEALTH, LABOUR AND WELFARE.ELEKTA AB - ITS ELEKTA UNITY MAGNETIC RESONANCE RADIATION THERAPY SYSTEM HAS BEEN APPROVED FOR CLINICAL USE IN JAPAN.  Full Article

Elekta buys quality assurance systems firm Acumyn
Friday, 27 Jul 2018 

July 27 (Reuters) - Elekta AB (publ) ::ELEKTA DIGITAL STRATEGY STRENGTHENED THROUGH ACQUISITION OF QUALITY ASSURANCE EXPERT ACUMYN.THIS FOLLOWS AN EXCLUSIVE AGREEMENT BETWEEN ELEKTA AND ACUMYN, SIGNED IN 2014, TO COMMERCIALIZE ITS INTEGRATED QUALITY MANAGEMENT SYSTEM, AQUA.AQUA IS A COMPREHENSIVE SOFTWARE PLATFORM THAT COORDINATES AND CENTRALIZES ALL OF THE QUALITY ASSURANCE TESTS THAT NEED TO BE PERFORMED IN A RADIOTHERAPY CLINIC.  Full Article

Elekta Unity receives CE mark
Monday, 18 Jun 2018 

June 18 (Reuters) - Elekta AB (publ) ::ELEKTA UNITY, WORLD'S FIRST HIGH-FIELD MR-LINAC, RECEIVES CE MARK.TODAY ANNOUNCED THAT ITS ELEKTA UNITY MAGNETIC RESONANCE RADIATION THERAPY (MR/RT) SYSTEM HAS RECEIVED CE MARK, CLEARING THE TECHNOLOGY FOR COMMERCIAL SALES AND CLINICAL USE IN EUROPE.  Full Article

Elekta Q4 adjusted EBITA below forecasts, dividend higher
Friday, 1 Jun 2018 

June 1 (Reuters) - Elekta AB (publ) ::Q4 GROSS ORDER INTAKE AMOUNTED TO SEK 4,656 M (4,366).Q4 ADJUSTED EBITA AMOUNTED TO SEK 918 M (779). ITEMS AFFECTING COMPARABILITY WAS SEK 0 M (-253).SAYS EIGHT ELEKTA UNITY ORDERS WERE BOOKED IN QUARTER.SAYS BOARD OF DIRECTORS PROPOSES A DIVIDEND OF SEK 1.40 (1.00) PER SHARE FOR FISCAL YEAR 2017/18.SAYS OUTLOOK FOR 18/19 NET SALES GROWTH OF AROUND 7 PERCENT, BASED ON CONSTANT EXCHANGE RATES.SAYS OUTLOOK FOR 18/19 EBITA MARGIN OF AROUND 20 PERCENT.SAYS RESPONSE IN CHINA REGARDING UNITY HAS BEEN VERY POSITIVE AND WE WILL INSTALL FIRST FIVE SYSTEMS DURING THIS CURRENT FISCAL YEAR.REUTERS POLL: ELEKTA FISCAL Q4 ORDER INTAKE SEEN AT SEK 4,684 MILLION, ADJUSTED EBITA AT SEK 959 MILLION, DIVIDEND AT 1.20 SEK/SHARE.  Full Article

Elekta's Gamma Knife system cleared for use by China
Monday, 5 Feb 2018 

Feb 5 (Reuters) - Elekta Ab (Publ) ::ELEKTA'S LEKSELL GAMMA KNIFE ICON RADIOSURGERY SYSTEM CLEARED FOR USE IN CHINA.  Full Article

C-Rad Updates On Delivery To Swedish Cancer Center
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - C-Rad Ab ::REG-UPDATE ON C-RAD DELIVERY OF ITS ADVANCED SURFACE TRACKING SOLUTION TO SWEDISH CANCER CENTER NYA KAROLINSKA SOLNA.SAYS ‍IS IN CLOSE DIALOGUE WITH CUSTOMER AND WITH ELEKTA TO DETERMINE STEPS FORWARD.​.  Full Article

Elekta reaches agreement in dispute with Stockholm County Council
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Elekta AB ::ELEKTA AND STOCKHOLM COUNTY COUNCIL AGREE ON CONSTRUCTIVE WAY FORWARD.SAYS ELEKTA AND STOCKHOLM COUNTY COUNCIL SIGNED A LETTER OF INTENT TODAY REGARDING THE AGREEMENT FROM DECEMBER 29, 2016.SAYS ‍ELEKTA WILL CONTINUE TO FULLY EQUIP NEW RADIATION THERAPY DEPARTMENT OF STOCKHOLM SOUTH GENERAL HOSPITAL (SÖS) AND TO PROVIDE BRACHYTHERAPY SOLUTIONS TO NEW KAROLINSKA SOLNA (NKS).SAYS STOCKHOLM COUNTY COUNCIL WILL HAVE THE POSSIBILITY TO SEEK A SEPARATE SOLUTION FOR THE REMAINING EXTERNAL BEAM EQUIPMENT AT NKS​.SAYS VALUE OF REMAINING PART OF CONTRACT IS EXPECTED TO BE APPROXIMATELY SEK 160 MILLION; INITIAL ORDER VALUE WAS APPROXIMATELY SEK 350 MILLION.SAYS ‍LETTER OF INTENT IS EXPECTED TO BE TURNED INTO A BINDING CONTRACT LATEST JANUARY 31, 2018​.  Full Article

UPDATE 1-Elekta beats forecasts as strong demand boosts fourth quarter

* Forecasts EBITA margin of around 19% (Adds CEO comments, background, detail, shares)